Healthcare provider profile · identity verified

Andrew J. Bartlett, D.O.

Internal Medicine · CHAMPAIGN, IL · NPI 1073520516

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	840	281
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	486	100
Lisinopril	Lisinopril	469	160
Metformin Hcl	Metformin Hcl	445	143
Amlodipine Besylate	Amlodipine Besylate	440	160
Levothyroxine Sodium	Levothyroxine Sodium	424	147
Simvastatin	Simvastatin	351	100
Omeprazole	Omeprazole	332	124
Pantoprazole Sodium	Pantoprazole Sodium	323	101
Losartan Potassium	Losartan Potassium	292	88
Gabapentin	Gabapentin	282	88
Hydrochlorothiazide	Hydrochlorothiazide	273	85
Metoprolol Succinate	Metoprolol Succinate	251	79
Trazodone Hcl	Trazodone Hcl	227	67
Jardiance	Empagliflozin	225	54
Furosemide	Furosemide	202	61
Citalopram Hbr	Citalopram Hydrobromide	158	49
Clonazepam	Clonazepam	145	25
Lorazepam	Lorazepam	144	28
Meloxicam	Meloxicam	142	40
Allopurinol	Allopurinol	140	46
Tramadol Hcl	Tramadol Hcl	139	49
Baclofen	Baclofen	138	37
Duloxetine Hcl	Duloxetine Hcl	135	41
Zolpidem Tartrate	Zolpidem Tartrate	132	31
Metoprolol Tartrate	Metoprolol Tartrate	131	39
Eliquis	Apixaban	126	33
Albuterol Sulfate Hfa	Albuterol Sulfate	121	44
Tamsulosin Hcl	Tamsulosin Hcl	119	44
Ozempic	Semaglutide	118	25
Potassium Chloride	Potassium Chloride	118	47
Fluticasone Propionate	Fluticasone Propionate	113	51
Alprazolam	Alprazolam	106	36
Rosuvastatin Calcium	Rosuvastatin Calcium	104	50
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	103	27
Alendronate Sodium	Alendronate Sodium	97	31
Glimepiride	Glimepiride	97	29
Carvedilol	Carvedilol	94	38
Ezetimibe	Ezetimibe	94	38
Glipizide	Glipizide	87	25
Sertraline Hcl	Sertraline Hcl	85	24
Bupropion Xl	Bupropion Hcl	79	23
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	79	32
Warfarin Sodium	Warfarin Sodium	79	18
Clopidogrel	Clopidogrel Bisulfate	75	29
Escitalopram Oxalate	Escitalopram Oxalate	75	28
Pregabalin	Pregabalin	73	19
Tizanidine Hcl	Tizanidine Hcl	71	28
Prednisone	Prednisone	64	29
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	62	16
Pravastatin Sodium	Pravastatin Sodium	62	20
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	61	suppressed
Spironolactone	Spironolactone	59	20
Olmesartan Medoxomil	Olmesartan Medoxomil	57	17
Atenolol	Atenolol	56	21
Januvia	Sitagliptin Phosphate	49	13
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	49	18
Irbesartan	Irbesartan	47	15
Ondansetron Hcl	Ondansetron Hcl	46	14
Celecoxib	Celecoxib	45	13
Metformin Hcl Er	Metformin Hcl	43	23
Fenofibrate	Fenofibrate,micronized	41	11
Naproxen	Naproxen	40	14
Paroxetine Hcl	Paroxetine Hcl	40	suppressed
Ipratropium Bromide	Ipratropium Bromide	39	15
Bupropion Hcl Sr	Bupropion Hcl	38	16
Montelukast Sodium	Montelukast Sodium	38	13
Pioglitazone Hcl	Pioglitazone Hcl	38	suppressed
Dicyclomine Hcl	Dicyclomine Hcl	37	11
Nano 2nd Gen Pen Needle	Pen Needle, Diabetic	37	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	36	13
Famotidine	Famotidine	36	20
Valsartan	Valsartan	36	11
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	35	suppressed
Fenofibrate	Fenofibrate Nanocrystallized	35	11
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	35	15
Nystatin	Nystatin	35	12
Verapamil Sr	Verapamil Hcl	35	suppressed
Nifedipine Er	Nifedipine	34	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	34	12
Xarelto	Rivaroxaban	33	13
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	31	11
Verapamil Er	Verapamil Hcl	31	suppressed
Fenofibrate	Fenofibrate	30	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	29	suppressed
Valacyclovir	Valacyclovir Hcl	29	13
Benazepril Hcl	Benazepril Hcl	28	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	28	12
Hydralazine Hcl	Hydralazine Hcl	28	11
Diazepam	Diazepam	27	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	27	11
Acetaminophen-Codeine	Acetaminophen With Codeine	26	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	26	suppressed
Lantus	Insulin Glargine,hum.Rec.Anlog	26	suppressed
Lovastatin	Lovastatin	26	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	26	suppressed
Clonidine Hcl	Clonidine Hcl	25	suppressed
Gemfibrozil	Gemfibrozil	25	suppressed
Temazepam	Temazepam	25	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	24	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	24	suppressed
Levetiracetam	Levetiracetam	24	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	24	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	23	suppressed
Finasteride	Finasteride	23	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	23	13
Methylphenidate Er	Methylphenidate Hcl	22	suppressed
Synthroid	Levothyroxine Sodium	22	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	22	13
Enalapril Maleate	Enalapril Maleate	21	suppressed
Glipizide Er	Glipizide	21	12
Donepezil Hcl	Donepezil Hcl	19	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Trulicity	Dulaglutide	19	suppressed
Linzess	Linaclotide	18	suppressed
Mounjaro	Tirzepatide	18	suppressed
Torsemide	Torsemide	18	suppressed
Aripiprazole	Aripiprazole	17	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	17	15
Fentanyl	Fentanyl	17	suppressed
Premarin	Estrogens, Conjugated	17	suppressed
Propranolol Hcl	Propranolol Hcl	17	suppressed
Estradiol	Estradiol	16	suppressed
Klor-Con M20	Potassium Chloride	16	suppressed
Meclizine Hcl	Meclizine Hcl	16	suppressed
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	16	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Humalog	Insulin Lispro	15	suppressed
Nebivolol Hcl	Nebivolol Hcl	15	suppressed
Novolog Flexpen	Insulin Aspart	15	suppressed
Desvenlafaxine Succinate Er	Desvenlafaxine Succinate	14	suppressed
Diclofenac Sodium	Diclofenac Sodium	14	suppressed
Memantine Hcl	Memantine Hcl	14	suppressed
Methocarbamol	Methocarbamol	14	suppressed
Ropinirole Hcl	Ropinirole Hcl	14	suppressed
Amoxicillin	Amoxicillin	13	suppressed
Butalbital-Acetaminophen-Caffe	Butalb/Acetaminophen/Caffeine	13	suppressed
Ibandronate Sodium	Ibandronate Sodium	13	suppressed
Lansoprazole	Lansoprazole	13	suppressed
Metolazone	Metolazone	13	suppressed
Repatha Sureclick	Evolocumab	13	suppressed
Sucralfate	Sucralfate	13	suppressed
Topiramate	Topiramate	13	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	13	suppressed
Creon	Lipase/Protease/Amylase	12	suppressed
Fludrocortisone Acetate	Fludrocortisone Acetate	12	suppressed
Ibuprofen	Ibuprofen	12	suppressed
Insulin Syringe	Syringe And Needle,insulin,1ml	12	suppressed
Phenobarbital	Phenobarbital	12	suppressed
Cefuroxime	Cefuroxime Axetil	11	suppressed
Cephalexin	Cephalexin	11	suppressed
Cilostazol	Cilostazol	11	suppressed
Dextroamphetamine-Amphetamine	Dextroamphetamine/Amphetamine	11	suppressed
Hydrocortisone	Hydrocortisone	11	suppressed
Hydroxychloroquine Sulfate	Hydroxychloroquine Sulfate	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Lamotrigine	Lamotrigine	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error